Ambulatory Long Length Urodynamics Evaluation with Glean Urodynamics System

This study is looking at the safety and performance of a new device called the Glean Urodynamics System. This system helps doctors understand how your bladder and urinary tract are working, both in the clinic and at home. You might be able to join if you are at least 22 years old, male or female, and your doctor thinks you need a urodynamics study (UDS) as part of your usual care. The main goal is to see how many people experience any problems with the Glean Urodynamics System up to 14 days after it's removed. The study is currently unclear on its recruitment status and plans to enroll about 101 participants.

Study design
This is an open-label, single-arm study, meaning all participants will receive the Glean Urodynamics System and everyone involved will know what treatment is being given. It aims to enroll about 101 participants.
What's involved
You will have the Glean Urodynamics System inserted for monitoring in the clinic, then wear it at home for up to 24 hours. The sensor will be removed within 24 hours, and you will provide a urine sample 7 days later.
Compensation
Not stated in the trial record.
Follow-up
You will have a follow-up phone call 14 days after the sensor is removed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07425015

Ambulatory Long Length URodynamics Evaluation

Recruiting
NAAges 22+Interventional
Bright Uro
~101 participants
Updated 2026-04-15 on ClinicalTrials.gov
What's tested:Glean Urodynamics System

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics System
Measured over From enrollment to 14 days after device removal
Urology
Urinary Bladder, Overactive
Benign Prostatic Hyperplasia
Urodynamics
Home Monitoring
Urinary Incontinence (UI)
Lower Urinary Tract Dysfunction
7 sites across 6 states
Maryland2
Missouri1
Ohio1
South Carolina1
South Dakota1
Texas1
  • Brittany Carter, DHSc, MPH · STUDY_DIRECTOR · Bright Uro

Opens a ready-to-send draft in your own email app — review before sending.

  • Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics SystemFrom enrollment to 14 days after device removal

    Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics System